Essential news and analysis for agribusiness leaders.
Biolstimulant growth isn’t just about new tech— it’s about the convergence of it and how companies apply it to drive deliver results.
A look at Miraterra technology along with its recent acquisition of Trace Genomics assets.
Not quite seed, not quite crop protection and not quite inoculants. Something else.
